News

2021 Mar 22

Apostolou Lab's Study: Understanding and Exploiting “Cell Identity Crisis” Provides Potential New Routes to Stem Cell Therapy, Cancer Treatment

Molecular "bookmarks," which allow cells to retain their characteristics during cell division, ensure fast reactivation of critical cell identity genes after cell division, according to investigators at Weill Cornell... Read more

2021 Mar 12

Dr. Melnick's Study Finds Cancer Cells May Evade Chemotherapy by Going Dormant

Cancer cells can dodge chemotherapy by entering a state that bears similarity to certain kinds of senescence, a type of “active hibernation” that enables them to weather the stress induced by aggressive treatments aimed at... Read more

2021 Feb 17

Landau Lab's Super-Sensitive Cancer Blood Test Earns “Top 10” Award from Clinical Research Forum

Cancer biologists at Weill Cornell Medicine have been awarded a 2021 Top 10 Clinical Research Achievement Award from the Clinical Research Forum for their study last year describing a highly sensitive blood test for... Read more

2021 Feb 04

Dr. Cerchietti's Findings - Tumor Microenvironment Seen as a New Player in Aggressive Lymphomas

The environment surrounding the cancerous cells of a lymphoma tumor has a strong influence on the progression of these blood-cell cancers and their responses to therapies, according to a study by Weill Cornell Medicine... Read more

2021 Feb 01

Dr. Melnick's Study - Scientists Identify Gene that Plays Critical Role in Immune Cell Development

Much of the three-dimensional architecture of the genome in antibody-producing immune cells is dependent on a gene called SMC3. When this gene is not working properly it can lead to improper immune cell development and to... Read more

2021 Jan 15

New Collaborations Awarded Funding from Starr Cancer Consortium

The Starr Cancer Consortium has awarded grant funding to three Weill Cornell Medicine-led multi-institution teams to advance their groundbreaking cancer research projects. The grants will support studies on mechanisms that... Read more

2021 Jan 15

Dr. Manuel Hidalgo Shows that Organoids Derived from Patients Can Inform Pancreatic Cancer Research

Scientists in recent years have found that tumor cells biopsied from cancer patients can be grown in the lab into specialized tissues called organoids that mimic many aspects of the organ from which they are derived. Now... Read more

2020 Nov 20

Dr. Jorge Moscat-Guillen's Study Published in Developmental Cell

Congratulations to Dr. Jorge Moscat-Guillen and co-author, Dr. Maria Diaz-Meco , on their publication, Research Reveals Why Some Tumors Have Different Makeup of Cells , which was published in Developmental Cell. Molecular... Read more

2020 Aug 20

Dr. Lewis Cantley Awarded Johnson & Johnson Dr. Paul Janssen Award for Biomedical Research

Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of the Champions of Science® Initiative. Lewis Cantley, Ph.D. Named 2020 Award Winner for the... Read more

2020 Jun 25

Dr. Jorge Moscat-Guillen's Study Published in Cancer Cell

Congratulations to Dr. Jorge Moscat-Guillen and co-author, Dr. Maria Diaz-Meco , on their publication, PKCλ/ι Loss Induces Autophagy, Oxidative Phosphorylation, and NRF2 to Promote Liver Cancer Progression , which was... Read more

2020 May 11

Dr. Lewis Cantley's episode on Peter Attia, M.D. blog: Episode #110 – Cancer metabolism, cancer therapies, and the discovery of PI3K

#110 – Lew Cantley, Ph.D.: Cancer metabolism, cancer therapies, and the discovery of PI3K " If I get a result that suddenly doesn't make sense, to me that's more exciting. . .if you figure out why it didn't work and what was... Read more

2020 Mar 23

Dr. Dan Landau's Study Illuminates Early Steps on the Road to Blood Cancers

Gene mutations that are thought to be very early events in the development of leukemias and other blood disorders appear to set the stage for malignancy by increasing the production of certain types of blood cells at the... Read more

2020 Feb 10

Most Comprehensive Whole-Genome Cancer Study To Date Catalogs Tumor-Driving Mutations

The scope of the DNA changes that drive cancers has been illuminated as never before in a set of studies by a large international scientific team including Weill Cornell Medicine researchers. In six studies published Feb. 5... Read more

2019 Nov 26

Dr. John Blenis' Lab Finds Alterations in Chromatin Architecture Drive Cancer Metastasis

A change in the protein composition of chromatin—the condensed, packaged form of DNA in the nucleus—boosts the expression of metastasis-related genes; blocking this change appears to stop tumor cells from forming new tumors... Read more

2019 Nov 21

MCC Investigators, led by Dr. Nasser Altorki, Awarded NCI Cancer Moonshot Grant

Weill Cornell Medicine has received a prestigious Cancer Moonshot grant from the National Cancer Institute’s Immuno-Oncology Translational Network (IOTN) to explore the mechanisms that allow slow-growing lung cancer lesions... Read more

Silvia Formenti, M.D., is pioneering the use of radiation for immunotherapy in cancer

2019 Sep 17

Dr. Silvia Formenti Awarded ASTRO Gold Medal for Contributions to Radiation Oncology

Dr. Silvia Formenti , chair of the Department of Radiation Oncology and the Sandra and Edward Meyer Professor of Cancer Research at Weill Cornell Medicine and radiation oncologist-in-chief at NewYork-Presbyterian/Weill... Read more

2019 Aug 16

Dr. Silvia Formenti Wins Roentgen Prize from Italy’s Accademia dei Lincei

Dr. Silvia Formenti , chair of the Department of Radiation Oncology and the Sandra and Edward Meyer Professor of Cancer Research at Weill Cornell Medicine, and radiation oncologist-in-chief at NewYork-Presbyterian/Weill... Read more

2019 Jul 30

Dr. Lewis Cantley Awarded Grant from Gray Foundation

Dr. Lewis Cantley , the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, has been awarded a grant from the Gray Foundation to study the genetic mutations that can lead to breast and... Read more

2019 Jun 18

Dr. Gina Lee Honored with 2019 Tri-Institutional Breakout Award

Dr. Gina Lee, a former postdoctoral fellow in the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine who has now joined the institution’s faculty, has won a 2019 Tri-Institutional Breakout Award for Junior... Read more

2019 May 15

Tools to Track the Molecular Evolution of Cancers

A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables them to track the molecular evolution of cancers. The tools should enable a better... Read more